A citation-based method for searching scientific literature


List of co-cited articles
960 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.
Alan J Thompson, Brenda L Banwell, Frederik Barkhof, William M Carroll, Timothy Coetzee, Giancarlo Comi, Jorge Correale, Franz Fazekas, Massimo Filippi, Mark S Freedman,[...]. Lancet Neurol 2018
25

Defining the clinical course of multiple sclerosis: the 2013 revisions.
Fred D Lublin, Stephen C Reingold, Jeffrey A Cohen, Gary R Cutter, Per Soelberg Sørensen, Alan J Thompson, Jerry S Wolinsky, Laura J Balcer, Brenda Banwell, Frederik Barkhof,[...]. Neurology 2014
21

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study.
Ludwig Kappos, Amit Bar-Or, Bruce A C Cree, Robert J Fox, Gavin Giovannoni, Ralf Gold, Patrick Vermersch, Douglas L Arnold, Sophie Arnould, Tatiana Scherz,[...]. Lancet 2018
437
17

Cortical demyelination and diffuse white matter injury in multiple sclerosis.
Alexandra Kutzelnigg, Claudia F Lucchinetti, Christine Stadelmann, Wolfgang Brück, Helmut Rauschka, Markus Bergmann, Manfred Schmidbauer, Joseph E Parisi, Hans Lassmann. Brain 2005
17

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis.
Xavier Montalban, Stephen L Hauser, Ludwig Kappos, Douglas L Arnold, Amit Bar-Or, Giancarlo Comi, Jérôme de Seze, Gavin Giovannoni, Hans-Peter Hartung, Bernhard Hemmer,[...]. N Engl J Med 2017
892
15

Pathological mechanisms in progressive multiple sclerosis.
Don H Mahad, Bruce D Trapp, Hans Lassmann. Lancet Neurol 2015
652
14

Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology.
Roberta Magliozzi, Owain Howell, Abhilash Vora, Barbara Serafini, Richard Nicholas, Maria Puopolo, Richard Reynolds, Francesca Aloisi. Brain 2007
916
14

Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque.
Josa M Frischer, Stephen D Weigand, Yong Guo, Nilufer Kale, Joseph E Parisi, Istvan Pirko, Jay Mandrekar, Stephan Bramow, Imke Metz, Wolfgang Brück,[...]. Ann Neurol 2015
341
14

Multiple sclerosis.
Alan J Thompson, Sergio E Baranzini, Jeroen Geurts, Bernhard Hemmer, Olga Ciccarelli. Lancet 2018
797
13

The relation between inflammation and neurodegeneration in multiple sclerosis brains.
Josa M Frischer, Stephan Bramow, Assunta Dal-Bianco, Claudia F Lucchinetti, Helmut Rauschka, Manfred Schmidbauer, Henning Laursen, Per Soelberg Sorensen, Hans Lassmann. Brain 2009
921
11

A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis.
Roberta Magliozzi, Owain W Howell, Cheryl Reeves, Federico Roncaroli, Richard Nicholas, Barbara Serafini, Francesca Aloisi, Richard Reynolds. Ann Neurol 2010
453
10

Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis.
Tomas Olsson, Lisa F Barcellos, Lars Alfredsson. Nat Rev Neurol 2017
452
10

Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis.
Owain W Howell, Cheryl A Reeves, Richard Nicholas, Daniele Carassiti, Bishan Radotra, Steve M Gentleman, Barbara Serafini, Francesca Aloisi, Federico Roncaroli, Roberta Magliozzi,[...]. Brain 2011
510
10

Multiple Sclerosis.
Daniel S Reich, Claudia F Lucchinetti, Peter A Calabresi. N Engl J Med 2018
987
10

The 2013 clinical course descriptors for multiple sclerosis: A clarification.
Fred D Lublin, Timothy Coetzee, Jeffrey A Cohen, Ruth A Marrie, Alan J Thompson. Neurology 2020
46
21

Multiple Sclerosis: Mechanisms and Immunotherapy.
Clare Baecher-Allan, Belinda J Kaskow, Howard L Weiner. Neuron 2018
388
9

Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging.
Assunta Dal-Bianco, Günther Grabner, Claudia Kronnerwetter, Michael Weber, Romana Höftberger, Thomas Berger, Eduard Auff, Fritz Leutmezer, Siegfried Trattnig, Hans Lassmann,[...]. Acta Neuropathol 2017
187
9

Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial.
Kathleen Hawker, Paul O'Connor, Mark S Freedman, Peter A Calabresi, Jack Antel, Jack Simon, Stephen Hauser, Emmanuelle Waubant, Timothy Vollmer, Hillel Panitch,[...]. Ann Neurol 2009
604
9

Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial.
Fred Lublin, David H Miller, Mark S Freedman, Bruce A C Cree, Jerry S Wolinsky, Howard Weiner, Catherine Lubetzki, Hans-Peter Hartung, Xavier Montalban, Bernard M J Uitdehaag,[...]. Lancet 2016
271
9

Multiple sclerosis.
Massimo Filippi, Amit Bar-Or, Fredrik Piehl, Paolo Preziosa, Alessandra Solari, Sandra Vukusic, Maria A Rocca. Nat Rev Dis Primers 2018
445
9

Immunopathology of multiple sclerosis.
Calliope A Dendrou, Lars Fugger, Manuel A Friese. Nat Rev Immunol 2015
9

Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis.
Kjetil Bjornevik, Marianna Cortese, Brian C Healy, Jens Kuhle, Michael J Mina, Yumei Leng, Stephen J Elledge, David W Niebuhr, Ann I Scher, Kassandra L Munger,[...]. Science 2022
266
9

Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis.
J William L Brown, Alasdair Coles, Dana Horakova, Eva Havrdova, Guillermo Izquierdo, Alexandre Prat, Marc Girard, Pierre Duquette, Maria Trojano, Alessandra Lugaresi,[...]. JAMA 2019
206
8

Deep gray matter volume loss drives disability worsening in multiple sclerosis.
Arman Eshaghi, Ferran Prados, Wallace J Brownlee, Daniel R Altmann, Carmen Tur, M Jorge Cardoso, Floriana De Angelis, Steven H van de Pavert, Niamh Cawley, Nicola De Stefano,[...]. Ann Neurol 2018
201
8

Progressive multiple sclerosis patients show substantial lesion activity that correlates with clinical disease severity and sex: a retrospective autopsy cohort analysis.
Sabina Luchetti, Nina L Fransen, Corbert G van Eden, Valeria Ramaglia, Matthew Mason, Inge Huitinga. Acta Neuropathol 2018
146
8

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension.
Raju Kapoor, Pei-Ran Ho, Nolan Campbell, Ih Chang, Aaron Deykin, Fiona Forrestal, Nisha Lucas, Bei Yu, Douglas L Arnold, Mark S Freedman,[...]. Lancet Neurol 2018
167
8

Association of Chronic Active Multiple Sclerosis Lesions With Disability In Vivo.
Martina Absinta, Pascal Sati, Federica Masuzzo, Govind Nair, Varun Sethi, Hadar Kolb, Joan Ohayon, Tianxia Wu, Irene C M Cortese, Daniel S Reich. JAMA Neurol 2019
159
8

Inflammatory cortical demyelination in early multiple sclerosis.
Claudia F Lucchinetti, Bogdan F G Popescu, Reem F Bunyan, Natalia M Moll, Shanu F Roemer, Hans Lassmann, Wolfgang Brück, Joseph E Parisi, Bernd W Scheithauer, Caterina Giannini,[...]. N Engl J Med 2011
705
8

Neurotoxic reactive astrocytes are induced by activated microglia.
Shane A Liddelow, Kevin A Guttenplan, Laura E Clarke, Frederick C Bennett, Christopher J Bohlen, Lucas Schirmer, Mariko L Bennett, Alexandra E Münch, Won-Suk Chung, Todd C Peterson,[...]. Nature 2017
8


The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+ T lymphocytes and B cells.
Joana Machado-Santos, Etsuji Saji, Anna R Tröscher, Manuela Paunovic, Roland Liblau, Galina Gabriely, Christian G Bien, Jan Bauer, Hans Lassmann. Brain 2018
232
7

Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple Sclerosis.
Xavier Montalban, Douglas L Arnold, Martin S Weber, Ivan Staikov, Karolina Piasecka-Stryczynska, Jonathan Willmer, Emily C Martin, Fernando Dangond, Sana Syed, Jerry S Wolinsky. N Engl J Med 2019
139
7

Ofatumumab versus Teriflunomide in Multiple Sclerosis.
Stephen L Hauser, Amit Bar-Or, Jeffrey A Cohen, Giancarlo Comi, Jorge Correale, Patricia K Coyle, Anne H Cross, Jerome de Seze, David Leppert, Xavier Montalban,[...]. N Engl J Med 2020
169
7

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
Stephen L Hauser, Amit Bar-Or, Giancarlo Comi, Gavin Giovannoni, Hans-Peter Hartung, Bernhard Hemmer, Fred Lublin, Xavier Montalban, Kottil W Rammohan, Krzysztof Selmaj,[...]. N Engl J Med 2017
861
7

Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials.
Ludwig Kappos, Jerry S Wolinsky, Gavin Giovannoni, Douglas L Arnold, Qing Wang, Corrado Bernasconi, Fabian Model, Harold Koendgen, Marianna Manfrini, Shibeshih Belachew,[...]. JAMA Neurol 2020
103
7

Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis.
Ivan Jelcic, Faiez Al Nimer, Jian Wang, Verena Lentsch, Raquel Planas, Ilijas Jelcic, Aleksandar Madjovski, Sabrina Ruhrmann, Wolfgang Faigle, Katrin Frauenknecht,[...]. Cell 2018
227
7

Role of B Cells in Multiple Sclerosis and Related Disorders.
Giancarlo Comi, Amit Bar-Or, Hans Lassmann, Antonio Uccelli, Hans-Peter Hartung, Xavier Montalban, Per Solberg Sørensen, Reinhard Hohlfeld, Stephen L Hauser. Ann Neurol 2021
62
11

Silent progression in disease activity-free relapsing multiple sclerosis.
Bruce A C Cree, Jill A Hollenbach, Riley Bove, Gina Kirkish, Simone Sacco, Eduardo Caverzasi, Antje Bischof, Tristan Gundel, Alyssa H Zhu, Nico Papinutto,[...]. Ann Neurol 2019
165
7

Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis.
Sung R Choi, Owain W Howell, Daniele Carassiti, Roberta Magliozzi, Djordje Gveric, Paolo A Muraro, Richard Nicholas, Federico Roncaroli, Richard Reynolds. Brain 2012
226
7

Iron and neurodegeneration in the multiple sclerosis brain.
Simon Hametner, Isabella Wimmer, Lukas Haider, Sabine Pfeifenbring, Wolfgang Brück, Hans Lassmann. Ann Neurol 2013
316
7

Blood neurofilament light chain as a biomarker of MS disease activity and treatment response.
Jens Kuhle, Harald Kropshofer, Dieter A Haering, Uma Kundu, Rolf Meinert, Christian Barro, Frank Dahlke, Davorka Tomic, David Leppert, Ludwig Kappos. Neurology 2019
225
7

An updated histological classification system for multiple sclerosis lesions.
Tanja Kuhlmann, Samuel Ludwin, Alexandre Prat, Jack Antel, Wolfgang Brück, Hans Lassmann. Acta Neuropathol 2017
273
7

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.
Chris H Polman, Stephen C Reingold, Brenda Banwell, Michel Clanet, Jeffrey A Cohen, Massimo Filippi, Kazuo Fujihara, Eva Havrdova, Michael Hutchinson, Ludwig Kappos,[...]. Ann Neurol 2011
7

Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis.
Martina Absinta, Luisa Vuolo, Anuradha Rao, Govind Nair, Pascal Sati, Irene C M Cortese, Joan Ohayon, Kaylan Fenton, María I Reyes-Mantilla, Dragan Maric,[...]. Neurology 2015
183
6

A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis.
Gavin Giovannoni, Giancarlo Comi, Stuart Cook, Kottil Rammohan, Peter Rieckmann, Per Soelberg Sørensen, Patrick Vermersch, Peter Chang, Anthony Hamlett, Bruno Musch,[...]. N Engl J Med 2010
542
6

Remyelination is extensive in a subset of multiple sclerosis patients.
Peter Patrikios, Christine Stadelmann, Alexandra Kutzelnigg, Helmut Rauschka, Manfred Schmidbauer, Henning Laursen, Per Soelberg Sorensen, Wolfgang Brück, Claudia Lucchinetti, Hans Lassmann. Brain 2006
529
6

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.
Stephen L Hauser, Emmanuelle Waubant, Douglas L Arnold, Timothy Vollmer, Jack Antel, Robert J Fox, Amit Bar-Or, Michael Panzara, Neena Sarkar, Sunil Agarwal,[...]. N Engl J Med 2008
6

Reassessing B cell contributions in multiple sclerosis.
Rui Li, Kristina R Patterson, Amit Bar-Or. Nat Immunol 2018
187
6

Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis.
Barbara Serafini, Barbara Rosicarelli, Roberta Magliozzi, Egidio Stigliano, Francesca Aloisi. Brain Pathol 2004
810
6

Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial.
Jeremy Chataway, Nadine Schuerer, Ali Alsanousi, Dennis Chan, David MacManus, Kelvin Hunter, Val Anderson, Charles R M Bangham, Shona Clegg, Casper Nielsen,[...]. Lancet 2014
269
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.